CompletedPhase 4NCT02308124
Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study
Studying Rare autonomic nervous system disorder
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Seoul National University Hospital
- Principal Investigator
- Kon ChuSeoul National University Hospital, Seoul, South Korea
- Intervention
- Midodrine(drug)
- Enrollment
- 87 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2016
Study locations (1)
- Seoul National University Hospital, Seoul, South Korea
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02308124 on ClinicalTrials.govOther trials for Rare autonomic nervous system disorder
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07089043A Study in Subjects With Neurogenic Orthostatic HypotensionCuraSen Therapeutics, Inc.
- RECRUITINGNANCT06841198Cardiovascular Function and Response to Stimulation Within the First Year After Spinal Cord InjuryKessler Foundation
- RECRUITINGNANCT07195903The STAND-UP StudySt. Francis Hospital, New York
- RECRUITINGNANCT06587841Noninvasive Spinal Cord Stimulation for Early SCIUniversity of British Columbia
- RECRUITINGPHASE2NCT06188663SalT Supplementation in Older Adults With Orthostatic Intolerance DisordersUniversity of Galway
- RECRUITINGNANCT05908760CO2 Rebreathing in nOH: A Proof-of-Concept Pilot StudyUniversity of Calgary
- ACTIVE NOT RECRUITINGNCT06439498Frequency of Orthostatic Hypotension in Patients Who Underwent ColonoscopyAnkara University
- RECRUITINGNANCT06027255Long COVID Immune ProfilingVanderbilt University Medical Center